Cancer

OGT Launches Myeloid MRD Panel for Sensitive AML Biomarker Detection

OGT's SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.

Cancer

How AI is Revolutionizing Cervical Cancer Screening

AI is transforming cervical cancer screening through advanced image recognition, risk prediction models, and improved accessibility.

Cancer

New Blood Test for HPV-Related Head and Neck Cancer

The blood test offers a noninvasive way to detect and monitor HPV-related head and neck cancer and supports early cancer diagnostics.

BioView Unveils Breakthrough Liquid Biopsy for HER2 Detection in Metastatic Breast Cancer

Dec 23, 2024 | Breast, Molecular Diagnostics

BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.

A New Liquid Biopsy Test for Early Pancreatic Cancer Detection

Dec 20, 2024 | Molecular Diagnostics, Pancreatic

PharusDx announced a liquid biopsy test that uses microRNA and CA19-9 biomarkers to detect early-stage pancreatic cancer.

AI-based Classifiers for Lung Cancer Subtyping Findings Presented

Dec 20, 2024 | Lung Cancer

The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.

New Blood Test Could Make Cancer Treatments Safer and More Effective

Dec 16, 2024 | Leukemia

Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.

AI-Powered Blood Test Spots Earliest Sign of Breast Cancer

Dec 13, 2024 | Breast, Mass Spectrometry Instruments

A new laser analysis and AI method capable of detecting stage 1a breast cancer with 98% accuracy offers an effective screening option.

New HPV Self-Testing Method Improves Cervical Cancer Screening

Dec 13, 2024 | Cervical (HPV)

A new method for HPV self-testing stratifies women into three risk groups, enhancing cervical cancer screening and follow-up care.

New AI Model Improves Immunohistochemistry Cancer Analysis with Superior Generalization

Dec 12, 2024 | Cancer

Lunit’s Universal Immunohistochemistry AI model analyzes diverse cancer types and IHC stains, enabling accurate biomarker analysis.

AI-based Tool Offers Highly Accurate Pancreatic Cancer Diagnostics

Dec 12, 2024 | Histology, Pancreatic

A new deep learning model classifies pancreatic ductal adenocarcinoma into molecular subtypes using cost-effective histopathology images.

Why ctDNA Monitoring is Critical in Early Melanoma Recurrence Detection

Dec 12, 2024 | Melanoma, Molecular Diagnostics

NeoGenomics’ study demonstrates how ctDNA monitoring enables earlier detection of MRD and recurrence risk in high-risk melanoma patients.

New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients

Dec 11, 2024 | Molecular Diagnostics, Prostate

The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

Dec 11, 2024 | Cervical (HPV)

Hologic underscores the importance of combined Pap and HPV testing as the gold standard for cervical cancer screening.

How Cancer ‘Fingerprint’ Can Improve Early Detection

Dec 10, 2024 | Cancer, Molecular Diagnostics

Researchers identified unique molecular “fingerprints” on ribosomes that can detect early-stage cancers using nanopore sequencing devices.

HPV Self-Sampling Is Being Put into Practice in Texas

Dec 9, 2024 | Cervical (HPV), Podcasts

In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, of BD, returns to discuss BD and MD Anderson’s HPV self-collection study.

Pancreatic Cancer Early-Detection Test Gets Positive Clinical Validation

Dec 9, 2024 | Pancreatic

Immunovia’s CLARITI study validated its next-generation test for early-stage pancreatic cancer, achieving 78% sensitivity and 94% specificity.

Genomic Testing Advances Lynch Syndrome Diagnosis and Cancer Treatment

Dec 6, 2024 | Colorectal, Molecular Diagnostics

A new study highlights the critical role of genomic testing in diagnosing Lynch syndrome and guiding treatment for inherited cancers.

Category: Cancer

Cancer

Cancer

Cancer